Skip to main content
Addgene
Open Menu

Enter a sequence to perform a BLAST-based search of Addgene plasmid sequence databases.

In Category

Filter By

1,043 results

Showing: 1001 - 1020 of 1043 results

  1. pAAV_BiVIPe4_GCaMP6f (AAV PHP.eB)

    Viral Prep
    #213859-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV_BiVIPe4_GCaMP6f (#213859). In addition to the viral particles, you will also receive purified pAAV_BiVIPe4_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the VIP interneuron-targeting enhancer E4. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Promoter
    Tags
    None
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only

  2. pAAV_BiVIPe4_GCaMP6f (AAV1)

    Viral Prep
    #213859-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV_BiVIPe4_GCaMP6f (#213859). In addition to the viral particles, you will also receive purified pAAV_BiVIPe4_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the VIP interneuron-targeting enhancer E4. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Promoter
    Tags
    None
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only

  3. pAAV_BiVIPe4_ChR2_mCherry (AAV1)

    Viral Prep
    #213856-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV_BiVIPe4_ChR2_mCherry (#213856). In addition to the viral particles, you will also receive purified pAAV_BiVIPe4_ChR2_mCherry plasmid DNA. Expression of mCherry-tagged channelrhodopsin-2 under the control of the VIP interneuron-targeting enhancer E4. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Promoter
    Tags
    mCherry
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only

  4. pAAV_BiVIPe4_dTomato_nlsdTomato (AAV1)

    Viral Prep
    #213855-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV_BiVIPe4_dTomato_nlsdTomato (#213855). In addition to the viral particles, you will also receive purified pAAV_BiVIPe4_dTomato_nlsdTomato plasmid DNA. Bicistronic expression of dTomato and nuclear-targeted dTomato under the control of the VIP interneuron-targeting enhancer E4. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Promoter
    Tags
    dTomato
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only

  5. pAAV_BiCHATe27_ChR2_mCherry (AAV1)

    Viral Prep
    #213830-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV_BiCHATe27_ChR2_mCherry (#213830). In addition to the viral particles, you will also receive purified pAAV_BiCHATe27_ChR2_mCherry plasmid DNA. Expression of mCherry-tagged channelrhodopsin-2 under the control of the cholinergic neuron-targeting enhancer E27. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Promoter
    Tags
    mCherry
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only

  6. pAAV_BiCHATe27_dTomato_nlsdTomato (AAV1)

    Viral Prep
    #213829-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV_BiCHATe27_dTomato_nlsdTomato (#213829). In addition to the viral particles, you will also receive purified pAAV_BiCHATe27_dTomato_nlsdTomato plasmid DNA. Bicistronic expression of dTomato and nuclear-targeted dTomato under the control of the cholinergic neuron-targeting enhancer E27. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Promoter
    Tags
    dTomato
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only

  7. pAAV_BiSSTe10_GCaMP6f (AAV PHP.eB)

    Viral Prep
    #213818-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV_BiSSTe10_GCaMP6f (#213818). In addition to the viral particles, you will also receive purified pAAV_BiSSTe10_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the SST interneuron-targeting enhancer E10. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Promoter
    Tags
    None
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only

  8. pAAV_BiSSTe10_GCaMP6f (AAV1)

    Viral Prep
    #213818-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV_BiSSTe10_GCaMP6f (#213818). In addition to the viral particles, you will also receive purified pAAV_BiSSTe10_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the SST interneuron-targeting enhancer E10. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Promoter
    Tags
    None
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only

  9. pAAV_BiSSTe10_ChR2_mCherry (AAV1)

    Viral Prep
    #213815-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV_BiSSTe10_ChR2_mCherry (#213815). In addition to the viral particles, you will also receive purified pAAV_BiSSTe10_ChR2_mCherry plasmid DNA. Expression of mCherry-tagged channelrhodopsin-2 under the control of the SST interneuron-targeting enhancer E10. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Promoter
    Tags
    mCherry
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only

  10. pAAV_BiLAMP5e3_dTomato_nlsdTomato (AAV PHP.eB)

    Viral Prep
    #218792-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV_BiLAMP5e3_dTomato_nlsdTomato (#218792). In addition to the viral particles, you will also receive purified pAAV_BiLAMP5e3_dTomato_nlsdTomato plasmid DNA. Bicistronic expression of dTomato and nuclear-targeted dTomato under the control of the Lamp5 interneuron-targeting enhancer. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Promoter
    Tags
    None
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only

  11. pAAV_BiLAMP5e3_dTomato_nlsdTomato (AAV1)

    Viral Prep
    #218792-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV_BiLAMP5e3_dTomato_nlsdTomato (#218792). In addition to the viral particles, you will also receive purified pAAV_BiLAMP5e3_dTomato_nlsdTomato plasmid DNA. Bicistronic expression of dTomato and nuclear-targeted dTomato under the control of the Lamp5 interneuron-targeting enhancer. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Promoter
    Tags
    dTomato
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only

  12. pAAV_BiPVe4_eGFP (AAV PHP.eB)

    Viral Prep
    #221463-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV_BiPVe4_eGFP (#221463). In addition to the viral particles, you will also receive purified pAAV_BiPVe4_eGFP plasmid DNA. Expression of EGFP under the control of the chandelier cell-targeting enhancer E4. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Promoter
    Tags
    EGFP
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only

  13. pAAV_BiPVe4_eGFP (AAV1)

    Viral Prep
    #221463-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV_BiPVe4_eGFP (#221463). In addition to the viral particles, you will also receive purified pAAV_BiPVe4_eGFP plasmid DNA. Expression of EGFP under the control of the chandelier cell-targeting enhancer E4. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Promoter
    Tags
    EGFP
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only

  14. pAAV_BiSSTe4_GCaMP6f (AAV PHP.eB)

    Viral Prep
    #213947-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV_BiSSTe4_GCaMP6f (#213947). In addition to the viral particles, you will also receive purified pAAV_BiSSTe4_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the SST interneuron-targeting enhancer E4. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Promoter
    Tags
    None
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only

  15. pAAV_BiSSTe4_GCaMP6f (AAV1)

    Viral Prep
    #213947-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV_BiSSTe4_GCaMP6f (#213947). In addition to the viral particles, you will also receive purified pAAV_BiSSTe4_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the SST interneuron-targeting enhancer E4. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1
    Promoter
    Tags
    None
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only

  16. pAAV-syn-iGluSnFR4f-NGR-WPRE (AAV1)

    Viral Prep
    #234438-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-syn-iGluSnFR4f-NGR-WPRE (#234438). In addition to the viral particles, you will also receive purified pAAV-syn-iGluSnFR4f-NGR-WPRE plasmid DNA. Syn-driven, iGluSnFR4f-NGR sensor expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    GENIE Project
    Article
    Aggarwal et al bioRxiv 2025.03.20.643984
    Promoter
    Syn
    Tags
    None
    Available Since
    Sept. 22, 2025
    Availability
    Academic Institutions and Nonprofits only

  17. pAAV-syn-flex-iGluSnFR4f-NGR-WPRE (AAV1)

    Viral Prep
    #234442-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-syn-flex-iGluSnFR4f-NGR-WPRE (#234442). In addition to the viral particles, you will also receive purified pAAV-syn-flex-iGluSnFR4f-NGR-WPRE plasmid DNA. Syn-driven, iGluSnFR4f-NGR sensor expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    GENIE Project
    Article
    Aggarwal et al bioRxiv 2025.03.20.643984
    Promoter
    Syn
    Tags
    None
    Available Since
    Sept. 22, 2025
    Availability
    Academic Institutions and Nonprofits only

  18. pAAV-EF1a-Dio-ASAP5-Kv2.1-WPRE (AAV9)

    Viral Prep
    #225708-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-EF1a-Dio-ASAP5-Kv2.1-WPRE (#225708). In addition to the viral particles, you will also receive purified pAAV-EF1a-Dio-ASAP5-Kv2.1-WPRE plasmid DNA. EF1a-driven, Cre-dependent soma-targeted expression of genetically encoded voltage indicator ASAP5. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Michael Lin
    Article
    Hao et al Neuron. 2024 Sep 17:S0896-6273(24)00643-
    Promoter
    EF1α
    Tags
    None
    Available Since
    Sept. 22, 2025
    Availability
    Academic Institutions and Nonprofits only

  19. pX600-AAV-CMV::NLS-SaCas9-NLS-3xHA-bGHpA (AAV8)

    Viral Prep
    #61592-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pX600-AAV-CMV::NLS-SaCas9-NLS-3xHA-bGHpA (#61592). In addition to the viral particles, you will also receive purified pX600-AAV-CMV::NLS-SaCas9-NLS-3xHA-bGHpA plasmid DNA. CMV-driven expression of SaCas9. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Feng Zhang
    Article
    Ran et al Nature. 2015 Apr 1. doi: 10.1038/nature1
    Promoter
    Tags
    None
    Available Since
    Sept. 22, 2025
    Availability
    Academic Institutions and Nonprofits only

  20. pAAV-hSyn-DIO-EGFP (AAV9)

    Viral Prep
    #50457-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-hSyn-DIO-EGFP (#50457). In addition to the viral particles, you will also receive purified pAAV-hSyn-DIO-EGFP plasmid DNA. hSyn-driven, Cre-dependent EGFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Bryan Roth
    Promoter
    Syn
    Tags
    EGFP (Cre-dependent)
    Available Since
    Sept. 22, 2025
    Availability
    Academic Institutions and Nonprofits only
Showing: 1001 - 1020 of 1043 results